Peer
Reviewed Publications in International Journals (only English) 2000-2002
2003
1.
Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating
endothelial cells as markers for ANCA-associated small-vessel vasculitis.
Lancet 2003; 361(9353): 206-10. PDF
2. Woywodt A, Schroeder M, Mengel M, Schwarz A, Gwinner W, Haller H, Haubitz
M. Circulating endothelial cells are a novel marker of cyclosporine-induced
endothelial damage. Hypertension 2003; published online ahead of print Jan
20 PDF
______________________________________________________________________________
2002
1. Brandt D, Gimona M, Hillmann M, Haller H, Mischak H. Protein kinase C induces
actin reorganization via a Src- and Rho-dependent pathway. J Biol Chem. 2002
Mar 29
2. Dechend R, Muller D, Park JK, Fiebeler A, Haller H, Luft FC. Statins and
angiotensin II-induced vascular injury. Nephrol Dial Transplant. 2002 Mar;17(3):349-53.
3. Goerke A, Sakai N, Gutjahr E, Schlapkohl WA, Mushinski JF, Haller H, Kolch
W, Saito N, Mischak H. Induction of apoptosis by Protein kinase C delta is
independent of its kinase activity. J Biol Chem. 2002 Jun 7
4. Kettritz R, Scheumann J, Xu YX, Luft FC, Haller H. TNF-alpha-accelerated
apoptosis abrogates ANCA-mediated neutrophil respiratory burst by a caspase-dependent
mechanism. Kidney Int 2002;61:502-515.
5. Kielstein JT, Boger RH, Bode-Boger SM, Frolich JC, Haller H, Ritz E, Fliser
D. Marked increase of asymmetric dimethylarginine in patients with incipient
primary chronic renal disease. J Am Soc Nephrol 2002;13:170-176.
6. Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H,
Orfanos CE. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta,
-epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Int J Oncol. 2002 Apr;20(4):865-71.
7. Kusch A, Tkachuk S, Lutter S, Haller H, Dietz R, Lipp M, Dumler I. Monocyte-expressed
urokinase regulates human vascular smooth muscle cell migration in a coculture
model. Biol Chem. 2002 Jan;383(1):217-21.
8. Lauterbach B, Barbosa-Sicard E, Wang MH, Honeck H, Kargel E, Theuer J,
Schwartzman ML, Haller H, Luft FC, Gollasch M, Schunck WH. Cytochrome P450-dependent
eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension.
2002 Feb;39(2 Pt 2):609-13.
9. Lohn M, Muzzulini U, Essin K, Tsang SY, Kirsch T, Litteral J, Waldron P,
Conrad H, Klugbauer N, Hofmann F, Haller H, Luft FC, Huang Y, Gollasch M.
Cilnidipine is a novel slow-acting blocker of vascular L-type calcium channels
that does not target protein kinase C. J Hypertens. 2002 May;20(5):885-893.
10. Park JK, Fiebeler A, Muller DN, Mervaala EM, Dechend R, Abou-Rebyeh F,
Luft FC, Haller H. Lacidipine inhibits adhesion molecule and oxidase expression
independent of blood pressure reduction in angiotensin-induced vascular injury.
Hypertension. 2002 Feb;39(2 Pt 2):685-9.
11. Radermacher J, Ellis S, Haller H. Renal resistance index and progression
of renal disease. Hypertension. 2002 Feb;39(2 Pt 2):699-703.
12. Rosenthal O, Woywodt A, Kirschner P, Haller H. Vertebral Osteomyelitis
and Endocarditis of a Pacemaker Lead Due to Granulicatella (Abiotrophia) Adiacens.
Infection 2002; 30: 317-319.
13. Schwarz A, Haller H. Internist (Berl). 2002 May;43(5):595-6, 599-600,
603-6.
14. Stepanova V, Jerke U, Sagach V, Lindschau C, Dietz R, Haller H, Dumler
I. Urokinase-dependent human vascular smooth muscle cell adhesion requires
selective vitronectin phosphorylation by ectoprotein kinase CK2. J Biol Chem.
2002 Mar 22;277(12):10265-72.
15. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D,
Haller H, Dietz R, Luft FC. Angiotensin II induced inflammation in the kidney
and in the heart of double transgenic rats. BMC Cardiovasc Disord. 2002;2(1):3.
16. Walter R, Mischak H, Haller H. Haemodialysis, atherosclerosis and inflammation-identifying
molecular mechanisms of chronic vascular disease in ESDR patients. Nephrol
Dial Transplant. 2002;17 Suppl 3:24-9.
17. Woywodt A, Kielstein JT, Haller H. An uncommon cause of metabolic acidosis
in a haemodialysis patient. Nephrol Dial Transplant. 2002 May;17(5):929-30.
18. Woywodt A, Kiss A: Geophagia: The history of earth-eating. Journal of
the Royal Society of Medicine 2002; 95(3): 143-146.
19. Woywodt A, Bahlmann F, de Groot K, Haller H, Haubitz M. Circulating endothelial
cells: Life, death, and repair of the endothelial cell layer. Nephrology,
Dialysis, Transplantation 2002; 17: 1728-1730.
20. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M.
Circulating endothelial cells as markers for ANCA-associated small-vessel
vasculitis. Lancet 2002; published online ahead of print Dec 3 PDF
21. Woywodt A, Merkel S, Buth W, Haller H, Schwarz A. A swollen neck. Lancet
2002; 360: 1838 PDF
22. Zaitsev S, Buchwalow I, Haberland A, Tkachuk S, Zaitseva I, Haller H,
Bottger M. Histone H1-mediated transfection: role of calcium in the cellular
uptake and intracellular fate of H1-DNA complexes. Acta Histochem. 2002;104(1):85-92.
________________________________________________________________________________
2001
1. Buchwalow IB, Schulze W, Karczewski P, Kostic MM, Wallukat G, Morwinski
R, Krause EG, Muller J, Paul M, Slezak J, Luft FC, Haller H. Inducible nitric
oxide synthase in the myocard. Mol Cell Biochem. 2001; 217(1-2):73-82.
2. Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, Bierringer
M, Gulba D, Dietz R, Luft FC, Haller H. Amelioration of angiotensin II-induced
cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor.
Circulation. 2001 Jul 31;104(5):576-81.
3. Dechend R, Fiebler A, Lindschau C, Bischoff H, Muller D, Park JK, Dietz
R, Haller H, Luft FC. Modulating angiotensin II-induced inflammation by HMG
Co-A reductase inhibition. Am J Hypertens. 2001 Jun;14(6 Pt 2):55S-61S.
4. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau
C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae,
vascular dysfunction and pulmonary defects in caveolin-1 gene-disrupted mice.
Science. 2001 28; 293 (5539): 2449-52.
5. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H. Prolonged
cold preservation augments vascular injury independent of renal transplant
immunogenicity and function. Kidney Int. 2001;60(3):1173-81.
6. Fiebeler A, Schmidt F, Muller DN, Park JK, Dechend R, Bieringer M, Shagdarsuren
E, Breu V, Haller H, Luft FC. Mineralocorticoid Receptor Affects AP-1 and
Nuclear Factor-kappaB Activation in Angiotensin II-Induced Cardiac Injury.
Hypertension 2001;37(2):787-793.
7. Fliser D, Haller H. Angiotensin II subtype 1-receptor antagonists in the
treatment of diabetic nephropathy. J. Hypertens Suppl. 2001;19 Suppl 1:S57-60.
8. Hautmann MB, Wilting J, Haller H, Leutz A. Adenovirus-mediated gene transfer
as a tool to study angiogenesis in the chick embryo. Dev Genes Evol 2001;211:611-616.
9. Hoffmann S, Krause T, van Geel PP, Willenbrock R, Pagel I, Pinto YM, Buikema
H, van Gilst WH, Lindschau C, Paul M, Inagami T, Ganten D, Urata H: Overexpression
of the human angiotensin II type 1 receptor in the rat heart augments load
induced cardiac hypertrophy. J Mol Med. 2001; 79(10):601-8.
10. Kettritz R, Schreiber A, Luft FC, Haller H. Role of Mitogen-Activated
Protein Kinases in Activation of Human Neutrophils by Antineutrophil Cytoplasmic
Antibodies. J Am Soc Nephrol. 2001; 12(1):37-46.
11. Kielstein JT, Abou-Rebyeh F, Hafer C, Haller H, Fliser D. Right-sided
chest pain at the onset of haemodialysis. Nephrol Dial Transplant. 2001 Jul;
16(7):1493-5.
12. Kielstein JT, Boger RH, Bode-Boger SM, Frolich JC, Haller H, Ritz E, Fliser
D. Marked increase of asymmetric dimethylarginine in patients with incipient
primary chronic renal disease. J Am Soc Nephrol. 2002; 13(1):170-6.
13. Kielstein JT, Frolich JC, Haller H, Fliser D. ADMA (asymmetric dimethylarginine):
an atherosclerotic disease mediating agent in patients with renal disease?
Nephrol Dial Transplant. 2001 Sep;16(9):1742-5.
14. Kielstein JT, Helmchen U, Netzer KO, Weber M, Haller H, Floege J. Conversion
of Goodpasture’s syndrome into membranous glomerulonephritis. Nephrol
Dial Transplant. 2001; 16(10): 2082-2085.
15. Kirsch T, Wellner M, Luft FC, Haller H, Lippoldt A. Protein altered gene
expression in cerebral capillaries of stroke-prone spontaneously hypertensive
rats. Brain Res. 2001 Aug 10;910(1-2): 106-15.
16. Kohler M, Buchwalow IB, Alexander G, Christiansen M, Shagdarsuren E, Samoilova
V, Hartmann E, Mervaala EM, Haller H. Increased importin alpha protein expression
in diabetic nephropathy. Kidney Int. 2001 Dec;60(6):2263-2273.
17. Lohn M, Jessner W, Furstenau M, Wellner M, Sorrentino V, Haller H, Luft
FC, Gollasch M. Regulation of calcium sparks and spontaneous transient outward
currents by RyR3 in arterial vascular smooth muscle cells. Circ Res. 2001
Nov 23;89(11):1051-7.
18. Lohn M, Lauterbach B, Haller H, Pongs O, Luft FC, Gollasch M. Beta1-subunit
of BK channels regulates arterial wall [Ca2+] and diameter in mouse cerebral
arteries. J Appl Physiol 2001; 91:1350-1354.
19. Muller DN, Dechend R, Fiebeler A, Park JK, Haller H, Luft FC. Angiotensin-induced
inflammation and novel approaches to treatment. Adv Nephrol Necker Hosp. 2001;31:89-103.
20. Muller DN, Dechend R, Fiebeler A, Park JK, Haller H, Luft FC.Angiotensin-induced
inflammation and vascular injury. Contrib Nephrol. 2001;(135):138-52.
21. Muller DN, Heissmeyer V, Dechend R, Hampich F, Park JK, Fiebeler A, Shagdarsuren
E, Theuer J, Elger M, Pilz B, Breu V, Schroer K, Ganten D, Dietz R, Haller
H, Scheidereit C, Luft FC. Aspirin inhibits NF-kappaB and protects from angiotensin
II-induced organ damage. FASEB J. 2001 Aug;15(10):1822-1824.
22. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski
M, Koch KM, Haller H. Use of Doppler Ultrasonography to Predict the Outcome
of Therapy for Renal-Artery Stenosis. N Engl J Med. 2001;344(6):410-417.
23. Radermacher J, Weinkove R, Haller H. Techniques for predicting a favourable
response to renal angioplasty in patients with renovascular disease. Curr
Opin Nephrol Hypertens. 2001 Nov;10(6):799-805.
24. Stepanova V, Jerke U, Sagach V, Lindschau C, Dietz R, Haller H, Dumler
I. Urokinase-dependent human vascular smooth muscle cell adhesion requires
selective vitronectin phosphorylation by ecto-protein kinase CK2. J Biol Chem.
2001; 26.
25. Woywodt A, Herrmann A, Eisenberger U, Schwarz A, Haller H. The tell-tale
urinary chloride. Nephrol Dial Transplant. 2001 May; 16(5):1066-8.
26. Woywodt A, Schwarz A, Mengel M, Haller H, Zeidler H, Kohler L. Nephrotoxicity
of selective COX-2 inhibitors. J Rheumatol. 2001;28(9):2133-5.
27. Woywodt A, Kielstein JT, Winkler M. Clinical picture: Subphrenic abscess
due to rupture of the spleen. Lancet 2001; 358: 875.
28. Woywodt A, Haubitz M. Kutane Vaskulitis: Eine seltene Differentialdiagnose
atypischer Hautläsionen. Journal of Wound Healing 2001; 22: 24-
________________________________________________________________________________
2000
1.
Berger M, Schröder B, Däschlein J, Schneider W, Busjahn A, Buchwalow
I, Luft FC, Haller H. Chlamydia pneumoniae DNA in non-coronary atherosclerotic
plaques and circulating leukocytes. J Lab Clin Med 2000; 136(3):194-200.
2. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park J-K, Theuer J, Juepner
A, Gulba D, Mackman N, Haller H, Luft FC. AT1 receptor agonistic antibodies
from preeclemptic patients cause vascular cells to express tissue factor.
Circulation 2000; 101(20):2382–2387.
3. de Groot K, Haubitz M, Haller H. ANCA-assoziierter Vaskulitiden: Neue Konzepte
und Strategien in der Therapie. Internist (Berl) 2000; 41 (10): 1112-9.
4. Detjen KM, Brembeck FH, Welzel M, Kaiser A, Haller H, Wiedenmann B, Rosewicz
S. Activation of protein kinase C(& agr;) inhibits growth of pancreatic
cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci. 2000; 113:3025-35
5. Dong J, Radau B, Otto A, Muller E, Lindschau C, Westermann P. Profilin
I attached to the Golgi is required for the formation of constitutive transport
vesicles at the trans-Golgi network. Biochim Biophys Acta 2000; 1497(2):253-60
6. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H. Ischemia-reperfusion
injury in renal transplantation is independent of the immunological background.
Kidney Int. 2000; 58(5):2166-77.
7. Fürstenau M, Löhn M, Luft FC, Haller H, Gollasch M. Calcium sparks
in human coronary artery smooth muscle cells resolved by confocal imaging.
J Hypertens 2000; 18(9):1215-22.
8. Genersch E, Hayes K, Neuenfeld Y, Haller H. Sustained ERK phosphorylation
is necessary but not sufficient for MMP-9 regulation in endothelial cells:
involvement of Ras-dependent and –independent pathways. J Cell Sci.
2000; 113(Pt 23):4319-4330.
9. Gollasch M, Löhn M, Fürstenau M, Nelson MT, Luft FC, Haller H.
Ca2+ channels, "quantized" Ca2+ release, and differentiation of
myocytes in the cardiovascular system. J Hypertens 2000; 18(8):989-98.
10. Gollasch M, Lohn M, Furstenau M, Nelson MT, Luft FC, Haller H. Ca2+ channels,
Ca2+ sparks, and regulation of arterial smooth muscle function. Z Kardiol.
2000; 89 Suppl 2:15-9 Review.
11. Haberland A, Knaus T, Zaitsev SV, Buchberger B, Lun A, Haller H, Bottger
M. Histone H1-mediated transfection: serum inhibition can be overcome by Ca2+
ions. Pharm Res 2000; 17(2):229-35.
12. Haller H. Gefäßwand. Dtsch Med Wochenschr 2000; 125(17):58.
13. Jordan J, Toka HR, Heusser K, Toka O, Shannon JR, Tank J, Diedrich A,
Stabroth C, Stoffels M, Naraghi R, Oeklers W, Schuster H, Schobel HP, Haller
H, Luft FC. Severely impaired baroreflex-buffering in patients with monogenic
hypertension and neurovascular contact. Circulation. 2000; 102(21): 2611-8.
14. Kettritz R, Xu Y-X, Faass B, Klein JB, Müller E-C, Otto A, Busjahn
A, Luft FC, Haller H. TNFa-mediated neutrophil apoptosis involves Ly-GDI,
a Rho GTPase regulator. J Leukoc Biol 2000; 68(2):277-83.
15. Kusch A, Tkachuk S, Haller H, Dietz R, Gulba DC, Lipp M, Dumler I. Urokinase
stimulates human vascular smooth muscle cell migration via a Phosphatidylinositol
3-Kinase-Tyk2 interaction.J Biol Chem. 2000; 275(50):39466-39473.
16. Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, Haller H, Fuxe
K. Organization of choroid plexus epithelial and endothelial cell tight junctions
and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport
2000; 11(7):1427-31.
17. Lippoldt A, Jansson A, Kniesel U, Andbjer B, Andersson A, Wolburg H, Fuxe
K, Haller H. Phorbol ester induced changes in tight and adherens junctions
in the choroid plexus epithelium and in the ependyma. Brain Res. 2000; 854(1-2):197-206
18. Lippoldt A, Kniesel U, Liebner S, Kalbacher H, Kirsch T, Wolburg H, Haller
H. Structural alterations of tight junctions are associated with loss of polarity
in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial
cells. Brain Res. 2000; 885(2): 251-261
19. Lohn M, Furstenau M, Sagach V, Elger M, Schulze W, Luft FC, Haller H,
Gollasch M. Ignition of calcium sparks in arterial and cardiac muscle through
caveolai. Circ Res. 2000; 87 (11): 1043-9.
20. Maasch C, Wagner S, Lindschau C, Alexander G, Buchner K, Gollasch M, Luft
FC, Haller H. Protein kinase Calpha targeting is regulated by temporal and
spatial changes in intracellular free calcium concentration [Ca(2+)](i). FASEB
J 2000;14(11):1653-1663.
21. Mervaala E, Müller D, Park JK, Dechend R, Schmidt F, Fiebeler A,
Bieringer M, Breu V, Ganten D, Haller H, and Luft FC. Cyclosporin A protects
against angiotensin II-induced end-organ damage in double transgenic rats
harboring human renin and angiotensinogen genes. Hypertension 2000; 35 (1
Pt 2):360-6.
22. Mervaala E, Müller D, Schmidt F, Park J-K, Gross V, Bader M, Breu
V, Ganten D, Haller H, Luft FC. Blood pressure-independent effects in rats
with human renin and angiotensinogen genes. Hypertension 2000; 35:587-594.
23. Müller D, Mervaala EMA, Dechend R, Fiebeler A, Park J-K, Schmidt
F, Theuer J, Breu V, Mackman N, Luther T, Gulba D, Ganten D, Haller H, Luft
FC. Angiotensin (AT(1)) receptor blockade reduces vascular tissue factor in
angiotensin II-induced cardiac vasculopathy. Am J Pathol 2000; 157: 111-122.
24. Müller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A,
Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates
angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35(1
Pt 2):193-201.
25. Müller DN, Mervaala EMA, Schmidt F, Park JK, Dechend R, Genersch
E, Breu V, Löffler M-M, Schneider W, Ganten D, Haller H, Luft FC. Effect
of Bosentan on NF-kappaB, inflammation and tissue factor in angiotensin II-induced
end-organ damage. Hypertension 2000; 36 (2):282-90.
26. Park J-K, Mueller D, Mervaala E, Dechend R, Fiebeler A, Schmidt F, Bieringer
M, Schäfer O, Lindschau C, Schneider W, Ganten D, Luft FC, Haller H.
Cerivastatin prevents angiotensin II-induced renal injury independent of blood
pressure- and cholesterol-lowering effects. Kidney Int 2000; 58(4):1420-30.
27. Pluger S, Faulhaber J, Furstenau M, Lohn M, Waldschutz R, Gollasch M,
Haller H, Luft FC, Ehmke H, Pongs O. Mice with disrupted BK channel ss1 subunit
gene feature abnormal Ca(2+) Spark/STOC coupling and elevated blood pressure.
Circ Res. 2000; 87 (11): E53-60.
28. Fliser D, Haller H. Nephropathy in type 2 diabetes mellitus. Internist
(Berl) 2000;41(12):1363-73.
29. Woywodt A, Grommas U, Buth W, Rafflenbeul W: Adverse effects of drugs:
QT prolongation due to roxithromycin. Postgraduate Medical Journal 2000; 76:
651-653.
30. Woywodt A, Schneider W, Goebel U, Luft FC: Hypercalcemia due to talc granulomatosis.
Chest 2000; 177(4): 1195-1196.
31. Woywodt A, Herrmann A, Choi M, Göebel U, Luft FC: Turkish pepper
(extra hot). Postgraduate Medical Journal 2000; 76: 426-428.
32. Woywodt A, Knoblauch M, Choi M, Kettritz R, Göbel U: Sudden death
and Wegener's granulomatosis of the pituitary. Scandinavian Journal of Rheumatology
2000; 29; 264-266.
33. Woywodt A, Morack G, Kettritz R, Schneider W, Göbel U: Necrotizing
small-vessel vasculitis confined to the uterine cervix: 5 cases. Seminars
in Arthritis and Rheumatism 2000; 29: 368-372.
34. Woywodt A, Goebel U: Bronchial stenosis and excessive bronchiectasis due
to Wegener's granulomatosis. Nephron 2000; 85: 365-367.
35. Woywodt A, Choi M, Schneider W, Kettritz R, Göbel U. Cytomegalovirus
Colitis during mycophenolate therapy for Wegener's granulomatosis. American
Journal of Nephrology 2000; 20:468-472.
